Key facts
- It has raised $1.3M; the latest was Early Stage VC in Mar 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for AdCella
- ·The full record, as it builds
Funding rounds
No funding rounds for AdCella are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AdCella
Operator of a special purpose entity intended for advanced cancer treatments. The company develops multi-functional cellular immunotherapies for solid tumors, enabling healthcare professionals to provide proper treatment to cancer patients.
- Sector
- Healthcare
- HQ
- Parkville, Australia
- Founded
- 2024
- Ownership
- Privately Held (backing)
AdCella doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AdCella shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AdCella in its N-PORT filings yet. We sweep new filings monthly.